Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-05-29

FDA Approved: ZAFIRLUKAST — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for Zafirlukast from Strides Pharma Science Limited, indicating a labeling update to the already approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zafirlukast (zafirlukast)

Snippet

SUPPL AP for ZAFIRLUKAST (ZAFIRLUKAST)